Centre National de la Recherche Scientifique (CNRS);Université de Montpellier I;Université Montpellier II;University of Parma;Ecole Nationale Superieure De Chimie Montpellier (ENSC)
发明人:
申请号：
EP13306415.4
公开号：
EP2862568A1
申请日:
2013.10.15
申请国别(地区):
EP
年份:
2015
代理人:
摘要：
The present invention relates to a composition comprising an effective amount of urolithin A, urolithin B, urolithin C, urolithin D, or a combination thereof, for the stimulation of insulin secretion, and to the use of a compound chosen among urolithin A, urolithin B, urolithin C, urolithin D, or a combination thereof, for the stimulation of insulin secretion.The present invention also relates to a composition comprising an effective amount of urolithin B, urolithin C, urolithin D, or a combination thereof, for the treatment or the prevention of diabetes mellitus, and to the use of a compound chosen among urolithin B, urolithin C, urolithin D, and a combination thereof, for the treatment or the prevention of diabetes mellitus.
